{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:10:06Z","timestamp":1751461806172,"version":"3.41.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.dld.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T23:44:52Z","timestamp":1520379892000},"page":"1339-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Invitation letter with a standardized form is a reliable tool to exclude increased risk patients from organized fecal immunological testing-based colorectal cancer screening program"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-7493","authenticated-orcid":false,"given":"Adrien","family":"Sportes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Catajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakthiar","family":"Bejou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Marc","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Le Mab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Benamouzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March (5)","key":"10.1016\/j.dld.2018.02.008_bib0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"January (1)","key":"10.1016\/j.dld.2018.02.008_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dld.2013.07.017","article-title":"The impact of immunochemical faecal occult blood testing on colorectal cancer incidence","volume":"46","author":"Ventura","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"June (6)","key":"10.1016\/j.dld.2018.02.008_bib0015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10552-013-0201-5","article-title":"Meta-analyses of colorectal cancer risk factors","volume":"24","author":"Johnson","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.dld.2018.02.008_bib0020","first-page":"51","article-title":"European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication","volume":"45","author":"European Colorectal Cancer Screening Guidelines Working Group","year":"2013","journal-title":"Endoscopy"},{"issue":"August (8)","key":"10.1016\/j.dld.2018.02.008_bib0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.dld.2012.03.015","article-title":"Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme","volume":"44","author":"Faivre","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.02.008_bib0030","doi-asserted-by":"crossref","unstructured":"Sportes A, Bejou B, Catajar N, Benamouzig R. D\u00e9pistage du cancer colorectal \u2013 Encyclopedie Medico-Chirurgicale, October 2016. doi:10.1016\/S1155-1968(16)68982-4.","DOI":"10.1016\/s1155-1968(16)68982-4"},{"issue":"October (10)","key":"10.1016\/j.dld.2018.02.008_bib0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","article-title":"Colorectal cancer screening: a global overview of existing programmes","volume":"64","author":"Schreuders","year":"2015","journal-title":"Gut"},{"issue":"October (4)","key":"10.1016\/j.dld.2018.02.008_bib0040","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2007.07.023","article-title":"Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors","volume":"133","author":"Cottet","year":"2007","journal-title":"Gastroenterology"},{"issue":"December (18)","key":"10.1016\/j.dld.2018.02.008_bib0045","first-page":"3282","article-title":"Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial)","volume":"45","author":"Denis","year":"2009","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"July (1)","key":"10.1016\/j.dld.2018.02.008_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2036.2006.02966.x","article-title":"Low compliance with colonoscopic screening in first-degree relatives of patients with large adenomas","volume":"24","author":"Cottet","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818302068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818302068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:33:34Z","timestamp":1751459614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818302068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1590865818302068"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.02.008","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invitation letter with a standardized form is a reliable tool to exclude increased risk patients from organized fecal immunological testing-based colorectal cancer screening program","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}